Sarcomatoid renal cell carcinoma
MONDO:0003012A high grade carcinoma of the kidney. It is not a distinct clinicopathological entity and includes a diverse group of renal cell carcinomas which have been transformed from a lower to a higher grade.
Also known as: RCC w/ sarcomatoid features, renal cell carcinoma with sarcomatoid features, sarcomatoid renal cell cancer, sarcomatoid renal cell carcinoma, SRCC
2791 clinical trials for this condition and its sub-types, 15 tagged with Sarcomatoid renal cell carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New hope for rare cancers: Triple-Drug attack shows promise
Disease control Recruiting nowThis phase II trial is testing whether a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—can shrink or slow the growth of rare genitourinary cancers that have spread. About 314 adults with these uncommon tumors will receive the drugs. The goal is to see if the …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 16:00 UTC
-
Could a common food fiber boost immunotherapy in kidney cancer?
Disease control Recruiting nowThis study tests whether adding inulin gel, a fiber supplement, to standard immunotherapy drugs (ipilimumab and nivolumab) can help control advanced kidney cancer. About 55 adults with metastatic or locally advanced clear cell or sarcomatoid kidney cancer will take part. Research…
Phase 1/2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Could a gut bacteria boost cancer immunotherapy? new trial launches
Disease control Recruiting nowThis early-phase trial tests whether adding a live bacteria supplement (EXL01) to standard immunotherapy (nivolumab and ipilimumab) is safe and more effective for people with metastatic kidney cancer. About 33 participants will receive either the immunotherapy alone or with the s…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Gut bacteria boosts immunotherapy in kidney cancer trial
Disease control Recruiting nowThis phase 2 trial tests whether adding a live bacteria product called CBM588 to the immunotherapy drug pembrolizumab can help prevent kidney cancer from coming back after surgery. About 62 adults with high-risk clear cell or sarcomatoid kidney cancer will receive either pembroli…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Radioactive antibody hunt: could a new scan outsmart hidden kidney cancer?
Diagnosis Recruiting nowThis Phase II trial tests whether a special PET/CT scan using a radioactive tracer called 89Zr-DFO-girentuximab can find recurrent clear cell renal cell carcinoma after surgery better than standard contrast-enhanced CT. The tracer attaches to a protein (CAIX) on kidney cancer cel…
Phase 2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC